{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:28:47Z","timestamp":1778866127840,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1124\/dmd.116.073338","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T01:26:16Z","timestamp":1478049976000},"page":"76-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Interaction of 2,4-Diaminopyrimidine\u2013Containing Drugs Including Fedratinib and Trimethoprim with Thiamine Transporters"],"prefix":"10.1016","volume":"45","author":[{"given":"Marilyn M.","family":"Giacomini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayaraman","family":"Chandrasekhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolyn","family":"Twelves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Andrew","family":"Whitney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eve-Irene","family":"Lepist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian S.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.116.073338_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/bjh.13262","article-title":"Momelotinib treatment-emergent neuropathy: prevalence, risk factors and outcome in 100 patients with myelofibrosis","volume":"169","author":"Abdelrahman","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1124\/dmd.116.073338_bib2","doi-asserted-by":"crossref","first-page":"F796","DOI":"10.1152\/ajprenal.00078.2006","article-title":"Thiamin uptake by the human-derived renal epithelial (HEK-293) cells: cellular and molecular mechanisms","volume":"291","author":"Ashokkumar","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/dmd.116.073338_bib3","unstructured":"Bactrim. (1974) Package insert. Roche, Basel, Switzerland."},{"key":"10.1124\/dmd.116.073338_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/bj20031220","article-title":"Polarized expression of members of the solute carrier SLC19A gene family of water-soluble multivitamin transporters: implications for physiological function","volume":"376","author":"Boulware","year":"2003","journal-title":"Biochem J"},{"key":"10.1124\/dmd.116.073338_bib5","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0016-5085(94)90716-1","article-title":"Central nervous system Whipple\u2019s disease: relapse during therapy with trimethoprim-sulfamethoxazole and remission with cefixime","volume":"106","author":"Cooper","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.116.073338_bib6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/AAC.26.6.811","article-title":"Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges","volume":"26","author":"Dudley","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.116.073338_bib7","doi-asserted-by":"crossref","first-page":"31925","DOI":"10.1074\/jbc.274.45.31925","article-title":"Cloning of the human thiamine transporter, a member of the folate transporter family","volume":"274","author":"Dutta","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.116.073338_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1006\/mgme.2000.3112","article-title":"Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes","volume":"71","author":"Eudy","year":"2000","journal-title":"Mol Genet Metab"},{"key":"10.1124\/dmd.116.073338_bib9","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1074\/jbc.275.3.1699","article-title":"beta-lactam antibiotics as substrates for OCTN2, an organic cation\/carnitine transporter","volume":"275","author":"Ganapathy","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.116.073338_bib10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/clpt.2013.175","article-title":"Profiling solute carrier transporters in the human blood-brain barrier","volume":"94","author":"Geier","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.116.073338_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.116.073338_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1113\/jphysiol.1985.sp015889","article-title":"Comparison of the effects of some thiamine analogues upon thiamine transport across the blood-brain barrier of the rat","volume":"369","author":"Greenwood","year":"1985","journal-title":"J Physiol"},{"key":"10.1124\/dmd.116.073338_bib13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.1262110","article-title":"Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans","volume":"348","year":"2015","journal-title":"Science"},{"key":"10.1124\/dmd.116.073338_bib14","unstructured":"Jakafi. (2011) Package insert. Incyte Pharmaceuticals, Alapocas, DE."},{"key":"10.1124\/dmd.116.073338_bib15","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"10.1124\/dmd.116.073338_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11095-013-1144-y","article-title":"Investigation of endogenous compounds for assessing the drug interactions in the urinary excretion involving multidrug and toxin extrusion proteins","volume":"31","author":"Kato","year":"2014","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.116.073338_bib17","doi-asserted-by":"crossref","first-page":"e53175","DOI":"10.1371\/journal.pone.0053175","article-title":"Glucose-induced down regulation of thiamine transporters in the kidney proximal tubular epithelium produces thiamine insufficiency in diabetes","volume":"7","author":"Larkin","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/dmd.116.073338_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejphar.2012.02.028","article-title":"Thiamine is a substrate of organic cation transporters in Caco-2 cells","volume":"682","author":"Lemos","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.116.073338_bib19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ki.2014.66","article-title":"Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat","volume":"86","author":"Lepist","year":"2014","journal-title":"Kidney Int"},{"key":"10.1124\/dmd.116.073338_bib20","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1021\/acs.molpharmaceut.5b00501","article-title":"Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3)","volume":"12","author":"Liang","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.116.073338_bib21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1021\/bi401618y","article-title":"Thiamin function, metabolism, uptake, and transport","volume":"53","author":"Manzetti","year":"2014","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.116.073338_bib22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1126\/science.aaa0355","article-title":"Human genomics. The human transcriptome across tissues and individuals","volume":"348","author":"Mel\u00e9","year":"2015","journal-title":"Science"},{"key":"10.1124\/dmd.116.073338_bib23","doi-asserted-by":"crossref","first-page":"G593","DOI":"10.1152\/ajpgi.00237.2013","article-title":"Adaptive regulation of human intestinal thiamine uptake by extracellular substrate level: a role for THTR-2 transcriptional regulation","volume":"305","author":"Nabokina","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/dmd.116.073338_bib24","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1124\/dmd.116.073338_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/bcmd.2000.0356","article-title":"Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport","volume":"27","author":"Neufeld","year":"2001","journal-title":"Blood Cells Mol Dis"},{"key":"10.1124\/dmd.116.073338_bib26","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/leu.2013.71","article-title":"Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis","volume":"27","author":"Pardanani","year":"2013","journal-title":"Leukemia"},{"key":"10.1124\/dmd.116.073338_bib27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/00365549850161610","article-title":"A rare case of cotrimoxazole-induced eosinophilic aseptic meningitis in an HIV-infected patient","volume":"30","author":"Patey","year":"1998","journal-title":"Scand J Infect Dis"},{"key":"10.1124\/dmd.116.073338_bib28","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1592\/phco.19.18.1456.30903","article-title":"Trimethoprim-sulfamethoxazole-induced tremor in an immunocompetent patients","volume":"19","author":"Patterson","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1124\/dmd.116.073338_bib29","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1634\/theoncologist.2013-0198","article-title":"AZD1480: a phase I study of a novel JAK2 inhibitor in solid tumors","volume":"18","author":"Plimack","year":"2013","journal-title":"Oncologist"},{"key":"10.1124\/dmd.116.073338_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0925-4439(01)00073-4","article-title":"SLC19A3 encodes a second thiamine transporter ThTr2","volume":"1537","author":"Rajgopal","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.116.073338_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nbt0214-119a","article-title":"Setback for JAK2 inhibitors","volume":"32","author":"Ratner","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1124\/dmd.116.073338_bib32","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1053\/j.gastro.2009.10.042","article-title":"Impaired intestinal vitamin B1 (thiamin) uptake in thiamin transporter-2-deficient mice","volume":"138","author":"Reidling","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.116.073338_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jcp.20492","article-title":"Developmental maturation of intestinal and renal thiamin uptake: studies in wild-type and transgenic mice carrying human THTR-1 and 2 promoters","volume":"206","author":"Reidling","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1124\/dmd.116.073338_bib34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0005-2736(02)00341-3","article-title":"Expression and promoter analysis of SLC19A2 in the human intestine","volume":"1561","author":"Reidling","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.116.073338_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/WNF.0000000000000083","article-title":"Putamina involvement in Wernicke encephalopathy induced by Janus Kinase 2 inhibitor","volume":"38","author":"Rodr\u00edguez-Pardo","year":"2015","journal-title":"Clin Neuropharmacol"},{"key":"10.1124\/dmd.116.073338_bib36","doi-asserted-by":"crossref","first-page":"G491","DOI":"10.1152\/ajpgi.00361.2003","article-title":"Expression and functional contribution of hTHTR-2 in thiamin absorption in human intestine","volume":"286","author":"Said","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/dmd.116.073338_bib37","doi-asserted-by":"crossref","first-page":"C645","DOI":"10.1152\/ajpcell.1999.277.4.C645","article-title":"Transport of thiamine in human intestine: mechanism and regulation in intestinal epithelial cell model Caco-2","volume":"277","author":"Said","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.116.073338_bib38","doi-asserted-by":"crossref","first-page":"e739","DOI":"10.1542\/peds.2004-1352","article-title":"Transient psychosis in an immune-competent patient after oral trimethoprim-sulfamethoxazole administration","volume":"115","author":"Saidinejad","year":"2005","journal-title":"Pediatrics"},{"key":"10.1124\/dmd.116.073338_bib39","unstructured":"Sanofi. (2013) Sanofi discontinues clinical development of investigational JAK2 agent fedratinib (SAR302503), Sanofi, Paris, France, 1\u20132."},{"key":"10.1124\/dmd.116.073338_bib40","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1474-4422(07)70104-7","article-title":"Wernicke\u2019s encephalopathy: new clinical settings and recent advances in diagnosis and management","volume":"6","author":"Sechi","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1124\/dmd.116.073338_bib41","unstructured":"Thorne Research, Inc. (2003) Thiamine. Alt Med Rev 8:59\u201362."},{"key":"10.1124\/dmd.116.073338_bib42","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0022-3565(25)22555-1","article-title":"Toxicity of cephaloridine to carnitine transport and fatty acid metabolism in rabbit renal cortical mitochondria: structure-activity relationships","volume":"270","author":"Tune","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.116.073338_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.leukres.2014.11.018","article-title":"A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis","volume":"39","author":"Verstovsek","year":"2015","journal-title":"Leuk Res"},{"key":"10.1124\/dmd.116.073338_bib44","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.leukres.2013.12.006","article-title":"Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitor","volume":"38","author":"Verstovsek","year":"2014","journal-title":"Leuk Res"},{"key":"10.1124\/dmd.116.073338_bib45","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.canep.2015.01.014","article-title":"Risk of Wernicke\u2019s encephalopathy and cardiac disorders in patients with myeloproliferative neoplasm","volume":"39","author":"Wu","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"10.1124\/dmd.116.073338_bib46","unstructured":"Xeljanz. (2012) Package insert. Pfizer, New York."},{"key":"10.1124\/dmd.116.073338_bib47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1476-4598-11-54","article-title":"Interferon regulatory factor 4 binding protein is a novel p53 target gene and suppresses cisplatin-induced apoptosis of breast cancer cells","volume":"11","author":"Yang","year":"2012","journal-title":"Mol Cancer"},{"key":"10.1124\/dmd.116.073338_bib48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/431216","article-title":"Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3","volume":"77","author":"Zeng","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1124\/dmd.116.073338_bib49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/jcph.218","article-title":"A randomized, placebo-controlled study of the pharmacokinetics, pharmacodynamics, and tolerability of the oral JAK2 inhibitor fedratinib (SAR302503) in healthy volunteers","volume":"54","author":"Zhang","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.116.073338_bib50","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1124\/dmd.114.058883","article-title":"The Janus kinase 2 inhibitor fedratinib inhibits thiamine uptake: a putative mechanism for the onset of Wernicke\u2019s encephalopathy","volume":"42","author":"Zhang","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.116.073338_bib51","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.mam.2012.07.006","article-title":"Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors","volume":"34","author":"Zhao","year":"2013","journal-title":"Mol Aspects Med"}],"updated-by":[{"DOI":"10.1124\/dmd.116.073338err","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000}}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624053091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624053091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.116.073338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:20:48Z","timestamp":1739902848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624053091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0090955624053091"],"URL":"https:\/\/doi.org\/10.1124\/dmd.116.073338","relation":{"erratum":[{"id-type":"doi","id":"10.1124\/dmd.116.073338err","asserted-by":"object"}]},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction of 2,4-Diaminopyrimidine\u2013Containing Drugs Including Fedratinib and Trimethoprim with Thiamine Transporters","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.116.073338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}